📰 Structural Genomics Consortium News
Structural Genomics Consortium News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Structural Genomics Consortium. Real-time updates on events, politics, business and more.
June 11, 2024
Emma Weiss Lawyer in Toronto focuses on complex tax implications and tax law, corporate finance, and securities and corporate law.
January 8, 2024
Developing and testing a drug candidate can take years of effort and billions of dollars of investment. Any shortcut that AI can offer could be a game changer
January 3, 2024
In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with ophthalmology to forge new paths in healthcare and drug discovery.
September 28, 2023
/PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a partnership with The...
September 28, 2023
X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science WALTHAM, Mass.; Sept. 28, 2023 (Business Wire) – X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partn...
September 28, 2023
X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through open science, announced that they have entered a collaboration...
August 15, 2023
How to keep up with the evolving landscape of drug discovery, from chemogenomic libraries to new modality drugs
July 11, 2023
Researchers at the University of Toronto are part of a global initiative to map every cell in the body.
December 16, 2022
Jupiter, FL (PRWEB) December 16, 2022 -- An upcoming segment of Advancements with Ted Danson will focus on innovations in antiviral drugs for emerging
November 7, 2022
When the COVID-19 pandemic struck, scientists, corporations and governments around the world scrambled to share research data and ideas to advance the understanding of the disease and produce life-saving vaccines and therapies in record time.